Posted by Michael Wonder on 20 May 2020
Global regulators commit to cooperate on observational research in the context of COVID-19
20 May 2020 - Regulators from around the world have agreed three priority areas for cooperation on observational research during COVID-19.
They will collaborate on pregnancy research, on medicines used in clinical practice and on vaccine safety and effectiveness monitoring.
High-quality observational research is an important complement to the evidence on the safety and effectiveness of vaccines and treatments for COVID-19 generated in randomised clinical trials. It is critical in understanding the safety and effectiveness of medicines when used in clinical practice for the prevention and treatment of COVID-19.
